Generic Portal

— Research Explorer

Can we do without chemotherapy? A perspective on the combinations nivolumab-chemotherapy and nivolumab–ipilimumab in metastatic gastric and esophageal cancer

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Journal	Therapeutic advances in medical oncology
Volume	14
DOIs	https://doi.org/10.1177/17588359221142788
Publication status	Published - 1 Jan 2022

checkpoint inhibitor, chemotherapy, combination immunotherapy, gastric cancer, oesophageal cancer

ID: 29720699